Pfizer Animal Health will buy Synbiotics Corp.

Kansas City animal health company Synbiotics Corp. said Wednesday that it will sell to Pfizer Animal Health. The deal is expected to close later this week.

In a release, the companies said Synbiotics shareholders would receive 30.6 cents a share in cash as part of the transaction, of which just less than 2 cents a share would be held in escrow for any claims about Synbiotics’ representations to Pfizer.

[Kansas City Business Journal]